MoonLake Immunotherapeutics (NASDAQ: MLTX) is under investigation by the DJS Law Group for possible securities fraud. The October 6, 2025, announcement has raised concerns among investors about potential violations of federal securities laws.

A new investigation by The Schall Law Firm examines possible securities law violations by MoonLake Immunotherapeutics. Investors in the NASDAQ-listed company may have an opportunity to participate in a fraud claim if they believe they have been impacted by these allegations.